Clinical Trials Directory

Trials / Unknown

UnknownNCT04373668

NightCAP: Reducing Hypnotic Drug Use and Improving Night-time Care

Reducing Hypnotic Drug Use and Improving Night-time Care for People Living With Dementia in Care Homes (NightCAP): A Randomised Factorial Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
720 (estimated)
Sponsor
University of Exeter · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Dementia is a devastating condition characterised by progressive loss of cognition leading to loss of independence and eventually death. One major unmet need, which remains a critical challenge for care provision, is the management of night-time care and sleep-related symptoms in people with dementia living in care homes. The causes and impacts of sleep disturbances in people with dementia in care homes are complex and multi-faceted, indicating the need of a whole-systems approach to the issue. It will require a tailored, person-centred approach which accounts for the environmental, personal and clinical factors contributing to the symptoms. The aim of this study is to evaluate the NightCAP intervention to improve treatment of sleep disturbance in people with dementia in care homes, with the goal of reducing sleep disturbance behaviour and reducing the use of hypnotic drugs. This will provide robust evidence to support guidance on night time care and improving hypnotic drug prescribing, both of which are major unmet needs in the care of people with dementia.

Detailed description

The main objective of this current study is to explore the effectiveness of specific benefits of key components of the Night Time Care Activities Programme- NightCAP. Particularly elements of sleep hygiene and personalised night-time care planning. There may also be additional benefit in combining NightCAP elements with pharmacological review protocol to enable management of all major contributing factors in sleep disturbance. This cluster-randomised trial will be delivered in 24 UK care homes. Participants will be individuals living with dementia and experiencing sleep disturbance, as well as staff who care for them. Homes will be randomly allocated to one of two arms: optimised usual care or the intervention arm. All homes will receive an optimised person-centred care module. The NightCAP intervention programme consists of three key elements: (i) personalised night-time care planning (supported staff training and implementation); (ii) structured sleep hygiene (staff training); and (iii) hypnotic drug review protocol (GP fact sheet and staff training). The primary outcome will be sleep disturbance at the end of the intervention. Secondary outcomes will be hypnotic drug use, quality of life, resident falls, job satisfaction, burden and coping in care staff, and cost effectiveness.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHypnotic Medication ReviewA training programme focused providing guidance on the review and withdrawal process of hypnotic drugs.
BEHAVIORALStructured Sleep HygieneTraining module on the principle of good sleep hygiene
BEHAVIORALNight Time Care Activities ProgrammeTraining and support package to assist in the development of a personalised night time care plan and support the implementation and dissemination of information within the care home environment

Timeline

Start date
2021-11-01
Primary completion
2023-04-30
Completion
2023-04-30
First posted
2020-05-04
Last updated
2022-07-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04373668. Inclusion in this directory is not an endorsement.